Show Summary Details
Page of

Calcitonin gene-related peptide: relevance for migraine 

Calcitonin gene-related peptide: relevance for migraine
Calcitonin gene-related peptide: relevance for migraine

Jes Olesen

and Inger Jansen-Olesen

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 28 January 2022

Chapter 13 gives an outline of the different studies that have led to the current high level of interest in calcitonin generelated peptide (CGRP) antagonism as a possible new treatment principle in migraine.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.